Marius Diehl

venture forum neckar eV provides matching services for investors and start-up companies. It offers technological, credential, and capital, financing, and credit services. The firm also provides funding advices. The company was founded by Stefan Reineck, Axel Krauss, and Tilmann Distelbarth in 2002 and is headquartered in Heilbronn, Germany.

Implandata Ophthalmic Products GmbH develops diagnosis tool for glaucoma therapy. Its technology Pro-IOP is an eye pressure measurement system consists of an implantable micro sensor, responsible for pressure sensing, an external hand held device, which is transferring energy to the micro sensor telemetrically and which is responsible for data read out and storage and a GSM module which can be connected with the hand held device for transfer of measurement data to a database, which can be accessed by the eye doctor in order to get information about the disease status of the patient. The company was founded by Max Georg Ostermeier and Stefan Meyer in January 2010 and is headquartered in Hannover, Germany.

BayernLB Capital Partner GmbH (BayernLB) is a Germany-based venture capital firm which was established in 2000. It is owned by Bayerische Landesbank. Formerly known as BayTech Venture Capital Beratungs GmbH, the firm changed their name to BayernLB Capital Partner GmbH in 2011. Located in Munich, the firm manages venture capital funds for a range of clients including the regional government-controlled Bayerische Landesbank, the European Investment Bank and other major institutional investors and insurance companies.

STOCO 19 GmbH develops and markets filter products for the treatment of polluted air. It offers air cleaning and moisturiation products. The services of the firm are analysis, detailed engineering, system design, production, mounting, commissioning, consulting, calculation services, and maintenance. The company was founded in 2009 and is headquartered in Heilbronn, Germany.

Medos Medizintechnik AG manufactures medical devices for cardiac surgery and peripheral applications. It focuses on the continuous development of therapy solutions for cardiac surgeons and perfusionists. The company was founded in 1987 and is headquartered in Stolberg, Germany.

Xenios AG develops and manufactures innovative devices for minimally invasive lung and heart support. Its novalung iLA, i–cor, and medos devices provide pulmonary and cardiac assist for a broad range of support levels on the unique XENIOS platform. The company is headquartered in Heilbronn, Germany.